Cargando…
Tranexamic acid for the prevention of postpartum haemorrhage: the TAPPH-1 pilot randomized trial and lessons learned for trials in Canadian obstetrics
Postpartum haemorrhage (PPH) is a leading cause of maternal morbidity and mortality. While tranexamic acid (TXA) reduces bleeding and transfusion requirements in established PPH, we sought to determine the feasibility of conducting a fully powered trial assessing the effect of prophylactic tranexami...
Autores principales: | Alam, Asim Q., Barrett, Jon, Callum, Jeannie, Kaustov, Lilia, Au, Shelly, Fleet, Andrew, Kiss, Alex, Choi, Stephen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10024764/ https://www.ncbi.nlm.nih.gov/pubmed/36934142 http://dx.doi.org/10.1038/s41598-023-30947-8 |
Ejemplares similares
-
Protocol for a pilot, randomised, double-blinded, placebo-controlled trial of prophylactic use of tranexamic acid for preventing postpartum haemorrhage (TAPPH-1)
por: Alam, Asim, et al.
Publicado: (2017) -
Tranexamic acid reduces blood loss in postpartum haemorrhage
por: Ducloy-Bouthors, A, et al.
Publicado: (2010) -
Comparison effect of intravenous tranexamic acid and misoprostol for postpartum haemorrhage
por: Sahhaf, Farnaz, et al.
Publicado: (2014) -
High-dose tranexamic acid reduces blood loss in postpartum haemorrhage
por: Ducloy-Bouthors, Anne-Sophie, et al.
Publicado: (2011) -
The WOMAN Trial (World Maternal Antifibrinolytic Trial): tranexamic acid for the treatment of postpartum haemorrhage: an international randomised, double blind placebo controlled trial
por: Shakur, Haleema, et al.
Publicado: (2010)